Ingerid Brænne Arbo
Bakgrunn og aktiviteter
Ingerid Arbo er forsker med tilknytning til institutt for klinisk og molekylær medisin, fagenhet for klinisk medisin og metabolismerelaterte sykdommer / regionalt senter for fedmeforskning og innovasjon(ObeCe).
Forskningen er knyttet til fysisk aktivitet / inaktivitet og livsstil relatert til frafallsproblematikk blant ungdom på yrkesfag i videregående skole og innovasjonsprosjektet Playpulse.
Curriculum
- Applikasjonsanalytiker forskning 100%, Helseplattformen AS fra 19.08.2019
- Forskningsrådgiver 100% kontor for forskningsstøtte, St. Olavs hospital 2018-2019
- Forskningskoordinator 50% forskningsavdelingen / NorCRIN, St. Olavs Hospital HF 2015-2017, 80% fra 2018.
- Forsker 50% IKM/IKOM, DMF/MH, NTNU 2015-2017, 20% fra 2018. Gjestetilknytning (0%) fra 1.7.2019.
- Forsker 20% regionalt senter for fedmeforskning og innovasjon, St, Olavs Hospital 2014-2017
- Rådgiver, prosessleder EU-fokus fedme 2013-2015
- PhD i medisinsk teknologi, NTNU, Trondheim 2010
- Stipendiat, Institutt for biologi, NTNU, Trondheim 2005-2009
- Cand. scient i cellebiologi for medisinsk teknisk personell, NTNU, Trondheim 2002
- Cand. mag i bioteknologi, NTNU, Trondheim 2001
- Overingeniør, Institutt for sirkulasjon og bildediagnostikk, NTNU, Trondheim CERG,1996-2013
- Bioingeniør, Avd. for klinisk kjemi, Regionsykehuset i Trondheim 1986-1996
- Fysiokjemiker, Kir. avd. lab og sentrallab, Ullevål sykehus, Oslo 1982-86
- Fysiokjemiker, Gastroenterologisk forskningslab, Regionsykehuset i Tromsø 1981-82
- Bioingeniør (fysiokjemiker), Trondheim 1980
Doktorgradsavhandling (2010): "Nutritional lifestyle changes – effects of dietary carbohydrate restriction in healthy obese and overweight humans"
Hovedfagsoppgave (2002): " Na+/H+ -exchanger ved hjertesvikt og trening: Ekspresjon i hjertevev målt ved kompetitiv RT-PCR"
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2017) The effect of hypergastrinemia following sleeve gastrectomy and pantoprazole on type 2 diabetes mellitus and beta-cell mass in Goto-Kakizaki rats. Journal of Endocrinological Investigation. vol. Published ahead of print.
- (2016) Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation. British Journal of Cancer. vol. 115 (2).
- (2016) Sleeve gastrectomy, but not duodenojejunostomy, preserves total beta-cell mass in Goto-Kakizaki rats evaluated by three-dimensional optical projection tomography. Surgical Endoscopy. vol. 30 (2).
- (2015) Exercise capacity in lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation: a national cross-sectional study. Norsk Epidemiologi, Supplement. vol. 25.
- (2015) Gastrin secretion after bariatric surgery - response to a protein-rich mixed meal following roux-en-y gastric bypass and sleeve gastrectomy: a pilot study in normoglycemic women. Obesity Surgery. vol. Published ahead of print.
- (2015) The effects of high intensity interval training in women with rheumatic disease: a pilot study. European Journal of Applied Physiology. vol. 115 (10).
- (2014) The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats. Surgical Endoscopy. vol. 29 (3).
- (2014) Peak oxygen uptake after cardiac rehabilitation: A randomized controlled trial of a 12-month maintenance program versus usual care. PLOS ONE. vol. 9 (9).
- (2013) Balanced caloric macronutrient composition downregulates immunological gene expression in human blood cells - adipose tissue responses diverges. Omics. vol. 17 (1).
- (2011) Insulin induces fatty acid desaturase expression in human monocytes. Scandinavian Journal of Clinical and Laboratory Investigation. vol. 71 (4).
- (2010) Moderate-Carbohydrate Diet Induces Changes in Leukocyte Gene Expression Patterns and Pro-Inflammatory Biomarkers Towards a More Healthy Phenotype, Compared to a High-Carbohydrate Diet. Journal of Nutrigenetics and Nutrigenomics. vol. 3 (2-3).
- (2009) Changes in Regulation of Metabolic and Immunological Pathways in Leukocytes Due to Alterations in Macronutrient Composition. Journal of Nutrigenetics and Nutrigenomics. vol. 2 (4-5).
- (2009) Pathological and physiological hypertrophies are regulated by distinct gene programs. European Journal of Cardiovascular Prevention & Rehabilitation. vol. 16 (6).
- (2008) A Nutrigenomcs Approach to Define a “Lifestyle Algorithm” to Be Used in Cardiovascular Disease Prevention, Diagnosis and Therapy. Journal of Nutrigenetics and Nutrigenomics. vol. 1 (1-2).
- (2008) Leukocytes – A Reliable Source For Genomewide Screening To Identify Dietary Responses. Journal of Nutrigenetics and Nutrigenomics. vol. 1 (6).
- (2006) Reduced pH and contractility in failing rat cardiomyocytes. Acta Physiologica. vol. 188.
- (2003) Chronic Exposure to Carbon Monoxide and Nicotine: Endothelin ETA Receptor Antagonism Attenuates Carbon Monoxide-Induced Myocardial Hypertrophy in Rat. Toxicology and Applied Pharmacology.
- (1999) Effect of magnesium infusion on bleeding time in healthy male volunteers. Scandinavian Journal of Clinical and Laboratory Investigation. vol. 59.
- (1999) Chronic carbon monoxide exposure in vivo induces myocardial endothelin-1 expression and hypertrophy in rat. Pharmacology and Toxicology. vol. 85.
- (1999) Chronic monoxide exposure in vivo induces myocardial endothelin-1 expression and hyperthrophy in rat. Pharmacology and Toxicology. vol. 85.